Endobetix For Profit
Endobetix is developing a nonsurgical implant for the treatment of type 2 diabetes. The implant mimics the hormonal benefits offered by bariatric surgery. Implanted endoscopically, the device diverts bile and pancreatic secretions from the duodenum to the jejunum.
Headquarters:
17 Tchelet Street, Misgav
Technology:
TeleHealth
Industry:
AgeTech